Sagility's AI growth strategy received a major boost after the healthcare services provider announced the acquisition of U.S.-based CareSeed, a company known for its healthcare quality analytics and HEDIS reporting solutions.
Alembic Pharma received a major regulatory boost after securing USFDA approval for its Tretinoin Cream USP, 0.025 percent. The development lifted investor sentiment, with Alembic Pharma shares gaining in trade following the announcement.
Jharkhand is building a multi-stakeholder model to end TB as the state government sets an ambitious target to eliminate tuberculosis by 2029. The announcement was made by Health Minister Irfan Ansari during a National Task Force meeting under...
.jpeg "Cancer Drug Crisis Exposes Stress in India's Price Control Model")
Cancer drug shortages highlight stress in India’s price control model as rising input costs challenge affordability, supply stability, and long-term pharma sustainability.
US FDA flags quality lapses at an Indian drug plant, raising import scrutiny concerns and reinforcing the need for strict data integrity and global manufacturing compliance.
.jpeg "India Must Stay Attractive for Innovation-Led Pharma Investment")
India must stay attractive for innovation-led pharma investment as policy, IP protection and faster approvals remain critical to drive next-gen therapies and global clinical research.
The Navi Mumbai MediCity project has taken a major step forward with the Maharashtra government signing a Memorandum of Understanding (MoU) with Cleveland Clinic, Brookfield Asset Management, and Arodhan Health City.
Global race for generic semaglutide gains pace ahead of patent expiry, with Hetero-Richter partnership highlighting rising competition and export opportunities for India.
AstraZeneca received approval for Enhertu Expansion in India as the company received regulatory approval for the expanded use of its breast cancer drug Enhertu. The approval from the Central Drugs Standard Control Organisation (CDSCO)...
Wockhardt aims to derive 50% revenue from novel drugs in five years, led by antibiotics like Zaynich, as it strengthens its innovation-driven pharma strategy.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")